The National Times - Struggling brewer Heineken to cut up to 6,000 jobs

Struggling brewer Heineken to cut up to 6,000 jobs


Struggling brewer Heineken to cut up to 6,000 jobs
Struggling brewer Heineken to cut up to 6,000 jobs / Photo: © ANP/AFP/File

Under-pressure Dutch brewer Heineken said Wednesday that it would scrap up to 6,000 jobs as it faces what it called "challenging market conditions" with beer volumes down compared to last year.

Change text size:

The company said it would be "accelerating productivity at scale to unlock significant savings, reducing 5,000 to 6,000 roles over the next two years".

"We remain prudent in our near-term expectations for beer market conditions," chief executive Dolf van den Brink said in a statement.

Van den Brink stunned the company last month by announcing that he would be stepping down after almost six years at the helm.

He told reporters he was leaving with "mixed emotions" after acknowledging that he had guided the company "through turbulent economic and political times".

"My priority for the coming months is to leave Heineken in the strongest possible position," he said.

Heineken employs around 87,000 people globally.

In October, the brewer had already announced it was cutting or reassigning 400 jobs as part of a reorganisation of its Amsterdam head office to take advantage of new technologies.

Top executives declined to specify where the bulk of the job cuts would come, but chief financial officer Harold van den Broek hinted they would come in Europe.

"Europe is a big part of our business," he told reporters. "And you see from the financial results also that it is very tough to drive a good operating leverage there."

"So we are focusing many of the initiatives to strengthen our European business, but not exclusively so," he said.

Beer volumes globally at the world's second-biggest brewer after AB InBev were down 2.4 percent in 2025, the firm reported in its annual results.

The decline was especially severe in Europe and the Americas, which dropped 4.1 percent and 3.5 percent, respectively.

In the fourth quarter of last year, total global beer volumes were down 2.8 percent.

Total annual sales for Heineken came in at 34.4 billion euros ($41 billion), compared to the 36.0 billion it banked in 2024.

Net profits were 2.7 billion euros, which the firm said was a 4.9 percent gain on last year when currency fluctuations were stripped out.

Looking ahead to 2026, Heineken forecast full-year organic operating profit growth of two to six percent, after a 4.4 percent rise last year to 4.4 billion euros.

S.O'brien--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: